the Investigation Into Beneficial Effects of High-dose Interferon Beta 1-a, Compared to Low-dose Interferon Beta 1-a in Moderate to Severe Covid-19

NCT04521400 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: High dose Interferon-beta 1a
DRUG: Lopinavir/Ritonavir
DRUG: Low dose Interferon-beta 1a

Sponsor

Shahid Beheshti University of Medical Sciences